Michael Dragunow

University of Auckland — New Zealand

Neuroscience · Life Sciences

36h-index5.9kcitations99works8.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(30), Neuroinflammation and Neurodegeneration Mechanisms(14), Ion channel regulation and function(10), Alzheimer's disease research and treatments(8), Epilepsy research and treatment(8)

Publications99 total

ANGI-08. DECODING VEGF SIGNALLING LANDSCAPES IN VARIOUS GLIOBLASTOMA TUMOUR MICROENVIRONMENTS
Neuro-Oncology·2025
A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementia
Neurobiology of Disease·2025Open Access
On the structural and practical identifiability of multi‐echo BBB‐ASL tracer kinetic models
Magnetic Resonance in Medicine·2025Open Access
A Novel Features-Driven Augmentation of DNA Methylation Microarrays to Enhance Meningioma Brain Tumors Classification using Transformer models
2025
In vitro models of microglia: a comparative study
Scientific Reports·2025· 13 citedOpen Access
Heterogeneity in pericyte inflammatory responses across age and species highlight the importance of human cell models
Molecular Brain·2025Open Access
Adenosine and Epileptic Seizures
2024· 4 cited
A meta-analysis of genetic variant pathogenicity and sex differences in <i>UBQLN2</i> -linked amyotrophic lateral sclerosis and frontotemporal dementia
2024Open Access
Phenotypic approaches for CNS drugs
Trends in Pharmacological Sciences·2024Open Access
Measurement of blood–brain barrier water exchange rate using diffusion‐prepared and multi‐echo arterial spin labelling: Comparison of quantitative values and age dependence
NMR in Biomedicine·2024· 15 citedOpen Access
AB001. Development of tumour-targeted therapy for the treatment of adult and paediatric high-grade gliomas
Chinese Clinical Oncology·2024Open Access
Hippocampal aggregation signatures of pathogenic <i>UBQLN2</i> in amyotrophic lateral sclerosis and frontotemporal dementia
Brain·2024· 9 citedOpen Access
Ultrastructural localization of Porphyromonas gingivalis gingipains in the substantia nigra of Parkinson’s disease brains
npj Parkinson s Disease·2024· 16 citedOpen Access
Aggregate-prone brain regions in Parkinson’s disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility
npj Parkinson s Disease·2024· 68 citedOpen Access
TMIC-23. UNRAVELLING THE HETEROGENEITY OF GLIOBLASTOMA'S VASCULAR LANDSCAPE
Neuro-Oncology·2023Open Access
Blood-brain barrier water exchange rate is associated with cognitive performance in mild cognitive impairment and early Alzheimer’s disease
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Scientific Reports·2022· 29 citedOpen Access
Reproducing traumatic brain injury in vitro with dielectric elastomer actuators
2022
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma
Pathology·2022· 20 cited
Hippocampal protein aggregation signatures fully distinguish pathogenic and wildtype <i>UBQLN2</i> in amyotrophic lateral sclerosis
2022· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Richard L. M. Faull(14), P. Lawlor(8), Maurice A. Curtis(7), Deborah Young(7), Matthew J. During(4), Wickliffe C. Abraham(4), M. Walton(4), Ernest Sirimanne(4), Karl Jansen(4), Paul E. Hughes(4), G.A. MacGibbon(4), Hannah M. Gibbons(4), Clinton Turner(4), Edward Mee(4), Patrick Schweder(4), Peter Heppner(4), Pritika Narayan(4), Andree G. Pearson(3), J. M. Greenwood(3), Graham V. Goddard(3)